Literature DB >> 10461925

Noninvasive measurements of [1-(13)C]glycogen concentrations and metabolism in rat brain in vivo.

I Y Choi1, I Tkác, K Ugurbil, R Gruetter.   

Abstract

Using a specific 13C NMR localization method, 13C label incorporation into the glycogen C1 resonance was measured while infusing [1-(13)C]glucose in intact rats. The maximal concentration of [1-(13)C]glycogen was 5.1 +/- 0.6 micromol g(-1) (mean +/- SE, n = 8). During the first 60 min of acute hyperglycemia, the rate of 13C label incorporation (synthase flux) was 2.3 +/- 0.7 micromol g(-1) h(-1) (mean +/- SE, n = 9 rats), which was higher (p < 0.01) than the rate of 0.49 +/- 0.14 micromol g(-1) h(-1) measured > or = 2 h later. To assess whether the incorporation of 13C label was due to turnover or net synthesis, the infusion was continued in seven rats with unlabeled glucose. The rate of 13C label decline (phosphorylase flux) was lower (0.33 +/- 0.10 micromol g(-1) h(-1)) than the initial rate of label incorporation (p < 0.01) and appeared to be independent of the duration of the preceding infusion of [1-(13)C]glucose (p > 0.05 for correlation). The results implied that net glycogen synthesis of approximately 3 micromol g(-1) had occurred, similar to previous reports. When infusing unlabeled glucose before [1-(13)C]glucose in three studies, the rate of glycogen C1 accumulation was 0.46 +/- 0.08 micromol g(-1) h(-1). The results suggest that steady-state glycogen turnover rates during hyperglycemia are approximately 1% of glucose consumption.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10461925     DOI: 10.1046/j.1471-4159.1999.0731300.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  30 in total

1.  Cerebral energetics and the glycogen shunt: neurochemical basis of functional imaging.

Authors:  R G Shulman; F Hyder; D L Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

2.  Quantitative assessment of brain glucose metabolic rates using in vivo deuterium magnetic resonance spectroscopy.

Authors:  Ming Lu; Xiao-Hong Zhu; Yi Zhang; Gheorghe Mateescu; Wei Chen
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-15       Impact factor: 6.200

Review 3.  Noninvasive measurement of brain glycogen by nuclear magnetic resonance spectroscopy and its application to the study of brain metabolism.

Authors:  Nolawit Tesfaye; Elizabeth R Seaquist; Gülin Oz
Journal:  J Neurosci Res       Date:  2011-07-05       Impact factor: 4.164

4.  A monopole/loop dual-tuned RF coil for ultrahigh field MRI.

Authors:  Xinqiang Yan; Rong Xue; Xiaoliang Zhang
Journal:  Quant Imaging Med Surg       Date:  2014-08

Review 5.  In vivo Magnetic Resonance Spectroscopy of cerebral glycogen metabolism in animals and humans.

Authors:  Ameer Khowaja; In-Young Choi; Elizabeth R Seaquist; Gülin Öz
Journal:  Metab Brain Dis       Date:  2014-03-28       Impact factor: 3.584

6.  Effect of hypoglycemia on brain glycogen metabolism in vivo.

Authors:  In-Young Choi; Elizabeth R Seaquist; Rolf Gruetter
Journal:  J Neurosci Res       Date:  2003-04-01       Impact factor: 4.164

Review 7.  In vivo NMR studies of neurodegenerative diseases in transgenic and rodent models.

Authors:  In-Young Choi; Sang-Pil Lee; David N Guilfoyle; Joseph A Helpern
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

Review 8.  Localized in vivo 13C NMR spectroscopy of the brain.

Authors:  Rolf Gruetter; Gregor Adriany; In-Young Choi; Pierre-Gilles Henry; Hongxia Lei; Gülin Oz
Journal:  NMR Biomed       Date:  2003 Oct-Nov       Impact factor: 4.044

Review 9.  Epilepsy, regulation of brain energy metabolism and neurotransmission.

Authors:  Jean-François Cloix; Tobias Hévor
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

10.  Human brain glycogen metabolism during and after hypoglycemia.

Authors:  Gülin Oz; Anjali Kumar; Jyothi P Rao; Christopher T Kodl; Lisa Chow; Lynn E Eberly; Elizabeth R Seaquist
Journal:  Diabetes       Date:  2009-06-05       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.